OSTX CIK: 1795091

OS Therapies Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
0.79
FY24:
5.53
FY25:
0.33
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.01
FY24:
0.01
FY25:
6.51
Total assets
Change from FY23 to FY25
millions USD
FY23:
0.80
FY24:
5.54
FY25:
6.84

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
24.7
FY24:
4.63
FY25:
11.8
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.10
FY24:
0.10
FY25:
0.10
(positive)
Change from FY23 to FY25
millions USD
FY23:
−24.0
FY24:
−3.27
FY25:
−6.10
Total liabilities & equity
millions USD
FY23:
0.80
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR